Fennec Pharmaceuticals's total assets for Q4 2025 were $70.07M, an increase of 42.37% from the previous quarter. TSE:FRX total liabilities were $35.02M for the fiscal quarter, a -34.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.